Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Effect of smoking and time on cognitive function in the elderly without dementia.

Reitz C, Luchsinger J, Tang MX, Mayeux R.

Neurology. 2005 Sep 27;65(6):870-5.

2.

Stroke and memory performance in elderly persons without dementia.

Reitz C, Luchsinger JA, Tang MX, Manly J, Mayeux R.

Arch Neurol. 2006 Apr;63(4):571-6.

3.

Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.

Mayeux R, Small SA, Tang M, Tycko B, Stern Y.

Neurobiol Aging. 2001 Jul-Aug;22(4):683-9.

PMID:
11445269
4.

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.

Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ.

Neurology. 2001 Dec 26;57(12):2217-22.

PMID:
11756600
5.

APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.

Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA.

Neurology. 2004 Oct 26;63(8):1399-402.

PMID:
15505155
7.

Alcohol consumption and cognitive function in late life: a longitudinal community study.

Ganguli M, Vander Bilt J, Saxton JA, Shen C, Dodge HH.

Neurology. 2005 Oct 25;65(8):1210-7.

PMID:
16247047
8.

The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.

Boyle PA, Buchman AS, Wilson RS, Kelly JF, Bennett DA.

Neuroepidemiology. 2010;34(1):43-9. doi: 10.1159/000256662. Epub 2009 Nov 11.

9.

APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.

Bunce D, Fratiglioni L, Small BJ, Winblad B, Bäckman L.

Neurology. 2004 Sep 14;63(5):816-21.

PMID:
15365129
10.

APOE genotype and cognitive decline in a middle-aged cohort.

Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E; Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Neurology. 2005 Jan 25;64(2):268-76.

PMID:
15668424
11.

Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.

Ma F, Wang J, Miao R, Zhao W, Wang Q.

Neuropsychobiology. 2011;64(2):102-9. doi: 10.1159/000324991. Epub 2011 Jun 21.

PMID:
21701228
12.

Impact of plasma lipids and time on memory performance in healthy elderly without dementia.

Reitz C, Luchsinger J, Tang MX, Manly J, Mayeux R.

Neurology. 2005 Apr 26;64(8):1378-83.

13.

Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.

DeCarli C, Mungas D, Harvey D, Reed B, Weiner M, Chui H, Jagust W.

Neurology. 2004 Jul 27;63(2):220-7.

14.

Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.

Qiu C, Winblad B, Fratiglioni L.

Neurol Res. 2006 Sep;28(6):650-6.

PMID:
16945218
15.

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.

Neurology. 2000 Apr 11;54(7):1492-7.

PMID:
10751265
16.

Substantial effects of apolipoprotein E ε4 on memory decline in very old age: longitudinal findings from a population-based sample.

Praetorius M, Thorvaldsson V, Hassing LB, Johansson B.

Neurobiol Aging. 2013 Dec;34(12):2734-9. doi: 10.1016/j.neurobiolaging.2013.06.002. Epub 2013 Jul 12.

PMID:
23855979
17.

Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.

Batterham PJ, Bunce D, Cherbuin N, Christensen H.

Am J Geriatr Psychiatry. 2013 Oct;21(10):1010-9. doi: 10.1016/j.jagp.2013.01.035. Epub 2013 Feb 6.

PMID:
23567378
18.

Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.

Caselli RJ, Reiman EM, Osborne D, Hentz JG, Baxter LC, Hernandez JL, Alexander GG.

Neurology. 2004 Jun 8;62(11):1990-5.

PMID:
15184602
19.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270
20.

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.

Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE; MacArthur Studies of Successful Aging.

Neurology. 2003 Apr 8;60(7):1077-81.

PMID:
12682309

Supplemental Content

Support Center